- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Karen B. DeSalvo Discusses the Importance of Patient Matching
One of the challenges of having interoperable healthcare systems includes perfecting patient matching so the right information connects with the right consumer, according to Karen B. DeSalvo, MD, MPH, former national coordinator for health information technology.
One of the challenges of having interoperable healthcare systems includes perfecting patient matching so the right information connects with the right consumer, according to Karen B. DeSalvo, MD, MPH, who stepped down Thursday as national coordinator for health information technology to take another position with HHS.
Patient matching may seem like mundane work, but it is critically important, and the industry is now very close to having an algorithm that will help identify if information like a problem list or medication list is matched with the right person.
“This is a safety issue, this is a privacy issue, this is a convenience issue, and a challenge that, as a country, we need to solve, so that we get it right,” Dr DeSalvo said.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More
